These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32249067)

  • 1. A Novel Risk Stratification Score for Sudden Cardiac Death Prediction in Middle-Aged, Nonischemic Dilated Cardiomyopathy Patients: The ESTIMATED Score.
    Li X; Fan X; Li S; Sun W; Shivkumar K; Zhao S; Lu M; Yao Y
    Can J Cardiol; 2020 Jul; 36(7):1121-1129. PubMed ID: 32249067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy.
    Di Marco A; Brown PF; Bradley J; Nucifora G; Claver E; de Frutos F; Dallaglio PD; Comin-Colet J; Anguera I; Miller CA; Schmitt M
    J Am Coll Cardiol; 2021 Jun; 77(23):2890-2905. PubMed ID: 34112317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.
    Halliday BP; Gulati A; Ali A; Guha K; Newsome S; Arzanauskaite M; Vassiliou VS; Lota A; Izgi C; Tayal U; Khalique Z; Stirrat C; Auger D; Pareek N; Ismail TF; Rosen SD; Vazir A; Alpendurada F; Gregson J; Frenneaux MP; Cowie MR; Cleland JGF; Cook SA; Pennell DJ; Prasad SK
    Circulation; 2017 May; 135(22):2106-2115. PubMed ID: 28351901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.
    Gulati A; Jabbour A; Ismail TF; Guha K; Khwaja J; Raza S; Morarji K; Brown TD; Ismail NA; Dweck MR; Di Pietro E; Roughton M; Wage R; Daryani Y; O'Hanlon R; Sheppard MN; Alpendurada F; Lyon AR; Cook SA; Cowie MR; Assomull RG; Pennell DJ; Prasad SK
    JAMA; 2013 Mar; 309(9):896-908. PubMed ID: 23462786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score.
    Todiere G; Nugara C; Gentile G; Negri F; Bianco F; Falletta C; Novo G; Di Bella G; De Caterina R; Zachara E; Re F; Clemenza F; Sinagra G; Emdin M; Aquaro GD
    Am J Cardiol; 2019 Oct; 124(8):1286-1292. PubMed ID: 31447011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and Sudden Cardiac Death Risk Stratification Using the Noninvasive Combination of Wide QRS Duration and Late Gadolinium Enhancement in Idiopathic Dilated Cardiomyopathy.
    Marume K; Noguchi T; Tateishi E; Morita Y; Kamakura T; Ishibashi K; Noda T; Miura H; Nishimura K; Nakai M; Yamada N; Tsujita K; Anzai T; Kusano K; Ogawa H; Yasuda S
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e006233. PubMed ID: 29654132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac MRI to Predict Sudden Cardiac Death Risk in Dilated Cardiomyopathy.
    Li Y; Xu Y; Li W; Guo J; Wan K; Wang J; Xu Z; Han Y; Sun J; Chen Y
    Radiology; 2023 May; 307(3):e222552. PubMed ID: 36916890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial Fibrosis as a Pathway of Prediction of Ventricular Arrhythmias and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy.
    Centurión OA; Alderete JF; Torales JM; García LB; Scavenius KE; Miño LM
    Crit Pathw Cardiol; 2019 Jun; 18(2):89-97. PubMed ID: 31094736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy.
    Neilan TG; Coelho-Filho OR; Danik SB; Shah RV; Dodson JA; Verdini DJ; Tokuda M; Daly CA; Tedrow UB; Stevenson WG; Jerosch-Herold M; Ghoshhajra BB; Kwong RY
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):944-54. PubMed ID: 23932642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
    Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
    Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD).
    Vehmeijer JT; Koyak Z; Leerink JM; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Robbers-Visser D; Groenink M; Boekholdt SM; de Winter RJ; Oliver JM; Bouma BJ; Budts W; Van Gelder IC; Mulder BJM; de Groot JR
    Heart Rhythm; 2021 May; 18(5):785-792. PubMed ID: 33465514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy.
    Miron A; Lafreniere-Roula M; Steve Fan CP; Armstrong KR; Dragulescu A; Papaz T; Manlhiot C; Kaufman B; Butts RJ; Gardin L; Stephenson EA; Howard TS; Aziz PF; Balaji S; Ladouceur VB; Benson LN; Colan SD; Godown J; Henderson HT; Ingles J; Jeewa A; Jefferies JL; Lal AK; Mathew J; Jean-St-Michel E; Michels M; Nakano SJ; Olivotto I; Parent JJ; Pereira AC; Semsarian C; Whitehill RD; Wittekind SG; Russell MW; Conway J; Richmond ME; Villa C; Weintraub RG; Rossano JW; Kantor PF; Ho CY; Mital S
    Circulation; 2020 Jul; 142(3):217-229. PubMed ID: 32418493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement.
    Halliday BP; Baksi AJ; Gulati A; Ali A; Newsome S; Izgi C; Arzanauskaite M; Lota A; Tayal U; Vassiliou VS; Gregson J; Alpendurada F; Frenneaux MP; Cook SA; Cleland JGF; Pennell DJ; Prasad SK
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1645-1655. PubMed ID: 30219397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Klopotowski M; Kukula K; Malek LA; Spiewak M; Polanska-Skrzypczyk M; Jamiolkowski J; Dabrowski M; Baranowski R; Klisiewicz A; Kusmierczyk M; Jasinska A; Jarmus E; Kruk M; Ruzyllo W; Witkowski A; Chojnowska L
    J Cardiol; 2016 Jul; 68(1):49-56. PubMed ID: 26363820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic role of late gadolinium enhancement on cardiac magnetic resonance in patients with nonischemic cardiomyopathy and reduced ejection fraction, implanted with cardioverter defibrillators for primary prevention. A systematic review and meta-analysis.
    Anagnostopoulos I; Kousta M; Kossyvakis C; Lakka E; Paraskevaidis NT; Schizas N; Alexopoulos N; Deftereos S; Giannopoulos G
    J Interv Card Electrophysiol; 2022 Apr; 63(3):523-530. PubMed ID: 34218421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
    Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular Arrhythmias and Sudden Death in Nonischemic Dilated Cardiomyopathy: Matter of Sex or Scar?
    Di-Marco A; Brown PF; Claver E; Bradley J; Nucifora G; Ruiz-Cueto M; Dallaglio PD; Rodriguez M; Comin-Colet J; Anguera I; Miller CA; Schmitt M
    J Card Fail; 2022 Aug; 28(8):1278-1286. PubMed ID: 35176484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis.
    Di Marco A; Anguera I; Schmitt M; Klem I; Neilan TG; White JA; Sramko M; Masci PG; Barison A; Mckenna P; Mordi I; Haugaa KH; Leyva F; Rodriguez Capitán J; Satoh H; Nabeta T; Dallaglio PD; Campbell NG; Sabaté X; Cequier Á
    JACC Heart Fail; 2017 Jan; 5(1):28-38. PubMed ID: 28017348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.